210344-92-6

210344-92-6 structure

Name: Z-VDVAD-FMK
Chemical Name: methyl 5-fluoro-3-[2-[[2-[[4-methoxy-2-[[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxopentanoate
CAS Number: 210344-92-6
Molecular Formula: C₃₂H₄₆FN₅O₁₁
Molecular Weight: 695.73
Catalog: Signaling Pathways Apoptosis Caspase
Create Date: 2016-12-12 03:47:18
Modify Date: 2024-01-09 11:23:30
Z-VDVAD-FMK is a special inhibitor of caspase-2. Z-VDVAD-FMK produces a reduction in Lovastatin-induced apoptosis[1][3][3].

Name	methyl 5-fluoro-3-[2-[[2-[[4-methoxy-2-[[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxopentanoate
Synonyms	Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-Fluoromethylketone FK016 Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-FMK Z-VD(OMe)VAD(OMe)-FMK

Description	Z-VDVAD-FMK is a special inhibitor of caspase-2. Z-VDVAD-FMK produces a reduction in Lovastatin-induced apoptosis[1][3][3].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Apoptosis >> Caspase
Target	Caspase-2
In Vitro	"Cotreatment of cells with the caspase inhibitors Ac-DEVD-CHO, Z-VDVAD-FMK (100μM), Z-IETD-fmk, and Z-LEHD-fmk alone or in combination, or overexpression of CrmA, prevents many morphological features of apoptosis but not loss of mitochondrial membrane potential (DCm), phospatidilserine exposure, and cell death[1]. Z-VDVAD-FMK (2 μM) greatly inhibits the Rho-kinase activity in HMEC-1 cells stimulated by Thrombin and displays no effect on control cells[2]. Z-VDVAD-FMK (zVDVAD-fmk) produces a reduction in Lovastatin-induced apoptosis. Z-VDVAD-FMK (100 μM) significantly reduces Lovastatin-induced loss of DNA by 19.1±8.3%[3]." Cell Viability Assay[1] Cell Line: The human T-cell leukemia Jurkat (Clone E6.1, ATCC TIB-152) Concentration: 100 μM Incubation Time: 22 hours Result: Prevented Doxorubicin (1 μM)-induced nuclear apoptosis, but not cell death.
References	[1]. S Gamen, et al. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells. Exp Cell Res. 2000 Jul 10;258(1):223-35. [2]. Cédric Sapet, et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood. 2006 Sep 15;108(6):1868-76. [3]. Simon W Rabkin, et al. Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors. Toxicol Appl Pharmacol. 2003 Dec 15;193(3):346-55.

Molecular Formula	C₃₂H₄₆FN₅O₁₁
Molecular Weight	695.73
Exact Mass	695.31800
PSA	241.85000
LogP	3.78290

210344-92-6	219138-08-6
133410-84-1	96922-64-4
1381885-28-4	105608-85-3
105637-38-5	210345-00-9
1135688-47-9	210344-95-9
1566672-23-8	1158522-08-7
1384079-14-4	2034357-44-1
112446-69-2	940364-43-2
134104-43-1	607723-70-6
131615-57-1	6906-52-1